Perceptive Advisors’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-90,000
Closed -$2.04M 105
2022
Q4
$2.04M Buy
+90,000
New +$2.51M 0.06% 85
2022
Q3
Sell
-273,423
Closed -$7.96M 122
2022
Q2
$7.96M Buy
273,423
+60,000
+28% +$1.53M 0.25% 68
2022
Q1
$5.71M Buy
+213,423
New +$5.04M 0.11% 99
2021
Q3
Sell
-135,000
Closed -$5.99M 152
2021
Q2
$5.99M Buy
+135,000
New +$4.98M 0.08% 120

Other funds holding PRVA

Perceptive Advisors's PRVA Position: Q1 2023 in Review

Perceptive Advisors sold out of Privia Health (PRVA) in Q1 2023, closing a stake of 90,000 shares — an estimated $2.04M sold.

Perceptive Advisors first reported a position in PRVA in Q2 2021 and held it in 4 quarters. The position peaked at $7.96M in Q2 2022. 191 funds tracked by Wall St. Rank hold PRVA as of Q1 2023.

  • Perceptive Advisors reported no remaining Privia Health position as of Q1 2023 after selling out during the quarter.
  • Perceptive Advisors sold 90,000 Privia Health shares in Q1 2023, an estimated $2.04M.
  • Perceptive Advisors first reported a position in Privia Health in Q2 2021 and held it in 4 quarters.
  • Perceptive Advisors's Privia Health position peaked at $7.96M in Q2 2022.
  • 191 funds tracked by Wall St. Rank held Privia Health as of Q1 2023.

Based on Perceptive Advisors's 13F filing for Q1 2023, filed 15 May 2023.